SEC CIK 1655299
Tapscott James F
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| OSBCview stock → | — | 2023-02-21 |
Position History — OSBC
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — OSBC
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2023-02-21 | Grant / award | 3,077 | $0.00 | — |
| 2022-02-15 | Grant / award | 3,080 | $0.00 | — |
| 2021-12-10 | Grant / award | 500 | $12.24 | — |
| 2021-08-19 | Open-market buy | 1,579 | $11.79 | 41,273 |
| 2021-03-08 | Tax withholding | 1,579 | $13.78 | 39,694 |
| 2021-02-16 | Grant / award | 3,773 | $0.00 | 41,273 |
| 2020-09-23 | Grant / award | 1,000 | $7.48 | 4,000 |
| 2020-03-04 | Grant / award | 2,000 | $10.71 | 3,000 |
| 2020-02-18 | Grant / award | 1,500 | — | 37,500 |
| 2019-06-03 | Grant / award | 1,500 | — | 36,000 |
| 2018-12-18 | Open-market buy | 1,000 | $12.89 | 1,000 |
| 2018-09-13 | Open-market buy | 500 | $15.30 | 34,500 |
| 2018-09-12 | Open-market buy | 500 | $15.35 | 34,000 |
| 2018-04-17 | Grant / award | 5,000 | — | 33,500 |
| 2018-02-20 | Grant / award | 1,500 | — | 28,500 |
| 2018-02-06 | Open-market buy | 1,000 | $13.38 | 27,000 |
| 2018-02-01 | Open-market buy | 1,000 | $14.25 | 26,000 |
| 2017-08-16 | Open-market buy | 2,500 | $11.59 | 25,000 |
| 2017-02-23 | Open-market buy | 2,500 | $10.88 | 22,500 |
| 2017-02-21 | Grant / award | 2,500 | — | 20,000 |
| 2017-02-08 | Open-market buy | 2,500 | $10.69 | 17,500 |
| 2017-01-31 | Open-market buy | 2,500 | $10.70 | 15,000 |
| 2016-05-12 | Open-market buy | 2,000 | $6.96 | 12,500 |
| 2016-02-16 | Grant / award | 2,500 | — | 10,500 |
| 2016-01-25 | Open-market buy | 1,000 | $6.38 | 8,000 |
| 2016-01-25 | Open-market buy | 2,000 | $6.37 | 7,000 |
| 2015-10-28 | Open-market buy | 5,000 | $10.10 | 5,000 |
| 2015-10-14 | — | — | — | 5,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.